Day Two of the historic March to Abolish Animal Testing in New York State is underway. It all kicked off in Albany on September 12th, 2026 with fiery speeches demanding an end to animal experimentation in an era of AI, quantum science, and organs-on-a-chip. After resting overnight in Schenectady, the resilient group of activists is tackling another grueling 15-mile trek toward the Amsterdam, New York area, where they’ve just arrived!
While 1,000 marchers have signed up overall, supporters continue to cycle in and out, with many joining individual legs of the journey. The ultimate destination is Marshall BioResources (MBR) in North Rose, New York—the nation's largest breeder of beagles for laboratory experimentation. Marchers are demanding the permanent closure of the facility and the immediate release of the estimated 16,000 to 20,000 beagles housed inside, mirroring the shutdowns of the notorious Envigo and Ridglan facilities.
Pressure continues to mount on MBR following a detailed 40-plus-page animal cruelty complaint submitted to the local district attorney by famed former prosecutor Bonnie Klapper. MBR denies the allegations, says it operates in compliance with USDA regulations, and has an open invitation to respond further. UnchainedTV's Jane Velez-Mitchell, Lindsey Baker, and reporter on the ground Jami Sassone are providing exclusive, daily LIVE coverage leading up to the high-stakes climax at the facility gates on September 26th.

KEY GOALS LISTED BY https://www.marchforanimals.org

End federal funding for animal experimentation. Advocate for reduced taxpayer funding of animal experiments and major investment in modern, human-relevant methods.

Ban the use of dogs in experimentation. Start with a focused, winnable species campaign that can build the foundation for wider protections.

Increase transparency and accountability. Push for disclosure, independent oversight, whistleblower protections, and stricter enforcement.

Shut down major breeding facilities. Sustain pressure on facilities such as Marshall BioResources and the larger commercial pipeline.